To investigate whether SNX-2112 could sensitize HeLa cancer cells to TRAIL-mediated apoptosis, HeLa cells were initially treated with 125 nM SNX-2112 or 200 ng/mL TRAIL alone or in combination for 48 h. Here, TNFSF10 is linked to cancer.